It doesn't sound like they're trying to kill them, since they're moving commercial usage to a subscription license.
I'm not sure killing them actually makes a lot of sense - the products apparently share a lot of code with esxi, so it's two products for the R&D of one.
I'm not sure killing them actually makes a lot of sense - the products apparently share a lot of code with esxi, so it's two products for the R&D of one.